Scarica l'app Stockscreener
29.53
1.57%
-0.47
Pre-mercato:
29.98
0.45
+1.52%
Precedente Chiudi:
$30.00
Aprire:
$29.75
Volume 24 ore:
554.71K
Relative Volume:
1.84
Capitalizzazione di mercato:
$488.36M
Reddito:
$3.25M
Utile/perdita netta:
$-116.80M
Rapporto P/E:
-9.682
EPS:
-3.05
Flusso di cassa netto:
$-98.17M
1 W Prestazione:
+0.65%
1M Prestazione:
+23.30%
6M Prestazione:
+322.15%
1 anno Prestazione:
+108.55%
Intervallo 1D:
$28.86
$30.00
Intervallo di 1 settimana:
$25.50
$42.39
Portata 52W:
$5.6652
$42.39
Rapt Therapeutics Inc Stock (RAPT) Company Profile
Nome
Rapt Therapeutics Inc
Settore
Industria
Telefono
(650) 489-9000
Indirizzo
561 ECCLES AVENUE, SOUTH SAN FRANCISCO, CA
Confronta RAPT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RAPT
Rapt Therapeutics Inc
|
29.53 | 496.13M | 3.25M | -116.80M | -98.17M | -3.05 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.39 | 108.36B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
463.43 | 60.82B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
577.95 | 61.02B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
817.32 | 50.01B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
310.81 | 34.05B | 4.56B | -176.77M | 225.30M | -1.7177 |
Rapt Therapeutics Inc Stock (RAPT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-20 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2025-10-13 | Iniziato | Barclays | Overweight |
| 2025-09-26 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-07-30 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2025-05-22 | Ripresa | H.C. Wainwright | Buy |
| 2024-12-26 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2024-11-13 | Downgrade | Stifel | Buy → Hold |
| 2024-11-11 | Downgrade | JP Morgan | Neutral → Underweight |
| 2024-11-11 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-05-14 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2024-05-10 | Downgrade | Barclays | Overweight → Equal Weight |
| 2024-05-10 | Downgrade | Guggenheim | Buy → Neutral |
| 2024-02-22 | Downgrade | UBS | Buy → Neutral |
| 2024-02-21 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2024-02-21 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-02-21 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-02-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2024-02-16 | Iniziato | Evercore ISI | Outperform |
| 2024-02-15 | Iniziato | Wolfe Research | Outperform |
| 2023-09-14 | Iniziato | Berenberg | Buy |
| 2023-08-09 | Iniziato | Stifel | Buy |
| 2023-06-15 | Iniziato | Barclays | Overweight |
| 2023-01-04 | Iniziato | Guggenheim | Buy |
| 2022-12-01 | Iniziato | Goldman | Buy |
| 2022-09-21 | Iniziato | CapitalOne | Overweight |
| 2022-05-24 | Ripresa | Cantor Fitzgerald | Overweight |
| 2021-12-09 | Iniziato | JP Morgan | Overweight |
| 2021-08-12 | Iniziato | SVB Leerink | Outperform |
| 2021-06-21 | Iniziato | Piper Sandler | Overweight |
| 2020-06-01 | Iniziato | H.C. Wainwright | Buy |
| 2020-05-19 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-04-13 | Iniziato | ROTH Capital | Buy |
| 2019-11-25 | Iniziato | BMO Capital Markets | Outperform |
| 2019-11-25 | Iniziato | UBS | Buy |
| 2019-11-25 | Iniziato | Wells Fargo | Outperform |
Mostra tutto
Rapt Therapeutics Inc Borsa (RAPT) Ultime notizie
Analyzing RAPT Therapeutics Inc. with multi timeframe chartsQuarterly Earnings Report & Verified Trade Idea Suggestions - newser.com
Why retail investors favor RAPT Therapeutics Inc. stockIPO Watch & Weekly Watchlist for Hot Stocks - newser.com
Tick level data insight on RAPT Therapeutics Inc. volatilityWeekly Earnings Recap & AI Driven Stock Price Forecasts - newser.com
Risk adjusted return profile for RAPT Therapeutics Inc. analyzedDividend Hike & AI Enhanced Trade Execution Alerts - newser.com
Published on: 2025-10-27 02:57:37 - newser.com
Can RAPT Therapeutics Inc. recover in the next quarterPortfolio Risk Summary & Comprehensive Market Scan Reports - newser.com
Is RAPT Therapeutics Inc. stock a buy for dividend growthJuly 2025 Recap & Fast Gain Swing Alerts - newser.com
What indicators show strength in RAPT Therapeutics Inc.Trade Performance Summary & Consistent Profit Focused Trading Strategies - newser.com
Published on: 2025-10-27 00:59:41 - newser.com
Does RAPT Therapeutics Inc. (0RA) stock trade below intrinsic value2025 Analyst Calls & Momentum Based Trading Signals - newser.com
Published on: 2025-10-26 23:23:14 - newser.com
Is RAPT Therapeutics Inc. stock reversal real or fakeDay Trade & Reliable Breakout Stock Forecasts - newser.com
Published on: 2025-10-26 21:27:10 - newser.com
Published on: 2025-10-26 20:42:00 - newser.com
Why RAPT Therapeutics Inc. (0RA) stock could break out in 2025Quarterly Earnings Report & Technical Entry and Exit Alerts - newser.com
Is RAPT Therapeutics Inc. (0RA) stock dividend growth reliableJuly 2025 Closing Moves & Verified Momentum Stock Ideas - newser.com
Published on: 2025-10-26 15:06:18 - newser.com
Leading vs lagging indicators on RAPT Therapeutics Inc. performanceInsider Selling & Technical Entry and Exit Tips - newser.com
Published on: 2025-10-26 10:44:52 - newser.com
Wells Fargo Boosts RAPT Therapeutics (RAPT) PT to $48 on Promising Anti-IgE Drug Data - Insider Monkey
Published on: 2025-10-26 00:53:27 - newser.com
Rapt Therapeutics Inc Azioni (RAPT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.11%
0.29%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):